Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | FAAH | O00519 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | CNR1 | P21554 | 1/20 | 0.63 |
| ▸ | CNR2 | P34972 | 1/20 | 0.63 |
| ▸ | PRKCA | P17252 | 3/20 | 0.62 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.62 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.62 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.53 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.47 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18632818 | 1.00 | MAPT (0.63) | MAPTFAAHALDH1A1HPGDCNR1 | |
| SCHEMBL18632815 | 1.00 | MAPT (0.63) | MAPTFAAHALDH1A1HPGDCNR1 | |
| SCHEMBL18632813 | 1.00 | MAPT (0.63) | MAPTFAAHALDH1A1HPGDCNR1 | |
| SCHEMBL28535971 | 1.00 | MAPT (0.63) | MAPTFAAHALDH1A1HPGDCNR1 | |
| SCHEMBL18632816 | 1.00 | MAPT (0.63) | MAPTFAAHALDH1A1HPGDCNR1 | |
| Cetyl Alcohol SCHEMBL27820648 | 0.92 | MAPT (0.76) | MAPTFAAHALDH1A1HPGDCNR1 | |
| SCHEMBL18623385 | 0.91 | PRKCA (0.64) | MAPTFAAHALDH1A1HPGDCNR1 | |
| SCHEMBL18623379 | 0.91 | PRKCA (0.64) | MAPTFAAHALDH1A1HPGDCNR1 | |
| SCHEMBL18623387 | 0.91 | PRKCA (0.64) | MAPTFAAHALDH1A1HPGDCNR1 | |
| SCHEMBL18623391 | 0.91 | PRKCA (0.64) | MAPTFAAHALDH1A1HPGDCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767278-B2 | Plant extract compositions for forming protective coatings | APEEL TECHNOLOGY, INC. (US) | 2023-09-26 | — | — | US | disclosed |
| EP-3649860-B1 | PLANT EXTRACT COMPOSITIONS FOR FORMING PROTECTIVE COATINGS | APEEL TECH INC (US) | 2023-02-01 | — | — | EP | disclosed |
| CN-112841185-A | Plant extract composition for forming protective coating | 阿比尔技术公司 | 2021-05-28 | — | — | CN | disclosed |
| CN-108966638-B | Plant extract composition for forming protective coating | 阿比尔技术公司 | 2021-01-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11767278-B2 | Plant extract compositions for forming protective coatings | CUTA, SHARPIN, BROX | MAPT 80/4885FAAH 1569/4885ALDH1A1 4754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.